Photo by camstejim from unsplash
Modulation of the endocannabinoid system via monoacylglycerol lipase inhibition with Lu AG06466 (formerly known as ABX‐1431) has previously been shown to reduce tics in patients with Tourette syndrome. Click to show full abstract
Modulation of the endocannabinoid system via monoacylglycerol lipase inhibition with Lu AG06466 (formerly known as ABX‐1431) has previously been shown to reduce tics in patients with Tourette syndrome.
Keywords:
monoacylglycerol lipase;
syndrome week;
inhibition tourette;
lipase inhibition;
tourette syndrome
Journal Title: Movement Disorders
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Movement Disorders
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!